Publikationen

Suchbegriffe: METABOLIC SYNDROME - METABOLISM , . Treffer: 6

2022

Koser, F; Hobbach, AJ; Abdellatif, M; Herbst, V; Türk, C; Reinecke, H; Krüger, M; Sedej, S; Linke, WA Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
Life Sci. 2022; 309:120998 Doi: 10.1016/j.lfs.2022.120998
Web of Science PubMed FullText FullText_MUG

 

2018

Merz, J; Albrecht, P; von Garlen, S; Ahmed, I; Dimanski, D; Wolf, D; Hilgendorf, I; Härdtner, C; Grotius, K; Willecke, F; Heidt, T; Bugger, H; Hoppe, N; Kintscher, U; von Zur Mühlen, C; Idzko, M; Bode, C; Zirlik, A; Stachon, P Purinergic receptor Y₂ (P2Y₂)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome.
Basic Res Cardiol. 2018; 113(6):45-45 Doi: 10.1007/s00395-018-0702-1
Web of Science PubMed FullText FullText_MUG

 

2017

Staaf, J; Labmayr, V; Paulmichl, K; Manell, H; Cen, J; Ciba, I; Dahlbom, M; Roomp, K; Anderwald, CH; Meissnitzer, M; Schneider, R; Forslund, A; Widhalm, K; Bergquist, J; Ahlström, H; Bergsten, P; Weghuber, D; Kullberg, J Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity.
Pancreas. 2017; 46(3): 358-365. Doi: 10.1097/MPA.0000000000000771 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Lerchbaum, E; Schwetz, V; Nauck, M; Völzke, H; Wallaschofski, H; Hannemann, A Lower bone turnover markers in metabolic syndrome and diabetes: the population-based Study of Health in Pomerania.
Nutr Metab Cardiovasc Dis. 2015; 25(5):458-463 Doi: 10.1016/j.numecd.2015.02.002
Web of Science PubMed FullText FullText_MUG

 

2014

Wolf, D; Jehle, F; Michel, NA; Bukosza, EN; Rivera, J; Chen, YC; Hoppe, N; Dufner, B; Rodriguez, AO; Colberg, C; Nieto, L; Rupprecht, B; Wiedemann, A; Schulte, L; Peikert, A; Bassler, N; Lozhkin, A; Hergeth, SP; Stachon, P; Hilgendorf, I; Willecke, F; von Zur Mühlen, C; von Elverfeldt, D; Binder, CJ; Aichele, P; Varo, N; Febbraio, MA; Libby, P; Bode, C; Peter, K; Zirlik, A Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.
Circulation. 2014; 129(23):2414-2425 Doi: 10.1161/CIRCULATIONAHA.113.008055 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Missiou, A; Wolf, D; Platzer, I; Ernst, S; Walter, C; Rudolf, P; Zirlik, K; Köstlin, N; Willecke, FK; Münkel, C; Schönbeck, U; Libby, P; Bode, C; Varo, N; Zirlik, A CD40L induces inflammation and adipogenesis in adipose cells--a potential link between metabolic and cardiovascular disease.
THROMB HAEMOSTASIS. 2010; 103(4): 788-796. Doi: 10.1160/TH09-07-0463
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz • Impressum